[Iatrogenic glucagonoma syndrome?].
Benhamou
P Y
PY
Service de Dermatologie, CHRU de Grenoble.
Reymond
J L
JL
Boizel
R
R
Béani
J C
JC
Amblard
P
P
D007516:Adenoma, Islet Cell / Q000139:chemically induced* / Q000150:complications*; D000596:Amino Acids / Q000097:blood; D005260:Female; D005934:Glucagon / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D005935:Glucagonoma / Q000139:chemically induced*; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy / Q000209:etiology; D007049:Iatrogenic Disease / Q000209:etiology*; D007340:Insulinoma / Q000150:complications*; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000139:chemically induced / Q000150:complications*; D012871:Skin Diseases / Q000209:etiology* / Q000473:pathology; D013577:Syndrome
D000596:Amino Acids; D005934:Glucagon
Un syndrome du glucagonome iatrogène?